Reviewing Editas Medicine (NASDAQ:EDIT) & Century Therapeutics (NASDAQ:IPSC)
Editas Medicine (NASDAQ:EDIT – Get Rating) and Century Therapeutics (NASDAQ:IPSC – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations. Analyst Recommendations This is a summary of recent ratings […]